The polycythemia vera-associated Jak2 V617F mutant induces tumorigenesis in nude mice
The polycythemia vera-associated Jak2 V617F mutant induces tumorigenesis in nude mice
复制标题
DOI:
10.1016/j.intimp.2009.03.011
复制
发表时间:
2009-07-01
影响因子:
5.6
通讯作者:
Kasahara, Tadashi
中科院分区:
文献类型:
--
作者:
Abe, Miyuki;Funakoshi-Tago, Megumi;Kasahara, Tadashi
The somatic Jak2 mutation (V617F) was identified in most patients with polycythemia vera (PV). Here, we show that the activating Jak2 V617F mutant completely protected Ba/F3 cells from cytokine withdrawal-induced apoptotic cell death. Interestingly, Ba/F3 cells expressing Jak2 V617F mutant induced rapid tumorigenesis in nude mice, leading to rapid death. Whereas an injection of Ba/F3 cells expressing wild-type Jak2 had no effect, an injection of Ba/F3 cells expressing Jak2 V617F mutant promptly invaded and spread into various distinct organs, such as the liver and spleen. Strikingly, Jak2 inhibitor, AG490 potently inhibited cytokine-independent cell growth induced by the Jak2 V617F mutant. Also, treatment with AG490 effectively delayed Jak2 V617F mutant-induced tumorigenesis in nude mice. Thus, our results both in vitro and in vivo suggest that Jak2 harboring V617F mutation is a potent oncogene able to promote cell transformation and tumorigenesis. (C) 2009 Elsevier B.V. All rights reserved.